Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | DNM1 | Q05193 | 5/20 | 0.42 |
| ▸ | FAAH | O00519 | 2/20 | 0.37 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7501921 | 1.00 | TSHR (0.52) | TSHRSMN1; SMN2DNM1FAAHTRPV1 | |
| SCHEMBL875345 | 1.00 | TSHR (0.52) | TSHRSMN1; SMN2DNM1FAAHTRPV1 | |
| SCHEMBL16987414 | 1.00 | TSHR (0.52) | TSHRSMN1; SMN2DNM1FAAHTRPV1 | |
| SCHEMBL1978740 | 1.00 | TSHR (0.52) | TSHRSMN1; SMN2DNM1FAAHTRPV1 | |
| SCHEMBL6892024 | 1.00 | TSHR (0.52) | TSHRSMN1; SMN2DNM1FAAHTRPV1 | |
| SCHEMBL1812024 | 1.00 | TSHR (0.52) | TSHRSMN1; SMN2DNM1FAAHTRPV1 | |
| SCHEMBL4053772 | 1.00 | TSHR (0.52) | TSHRSMN1; SMN2DNM1FAAHTRPV1 | |
| SCHEMBL21840780 | 0.98 | TSHR (0.54) | TSHRSMN1; SMN2DNM1FAAHTRPV1 | |
| SCHEMBL10529071 | 0.95 | TSHR (0.46) | TSHRSMN1; SMN2DNM1FAAHTRPV1 | |
| SCHEMBL418279 | 0.95 | TSHR (0.46) | TSHRSMN1; SMN2DNM1FAAHTRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2515772-A1 | COUPLING EMULSIONS FOR USE WITH ULTRASOUND DEVICES | Avon Products, Inc. (US) | 2012-10-31 | — | — | EP | disclosed |
| US-20120259252-A1 | Coupling Emulsions for Use With Ultrasound Devices | AVON PRODUCTS, INC. (US) | 2012-10-11 | — | — | US | disclosed |
| WO-2011078905-A1 | COUPLING EMULSIONS FOR USE WITH ULTRASOUND DEVICES | AVON PRODUCTS, INC. (US) | 2011-06-30 | — | — | WO | disclosed |
| EP-1663381-B1 | SONOPHORESIS SKIN CARE DEVICE | PROCTER & GAMBLE (US) | 2010-05-19 | — | — | EP | disclosed |
| EP-1641428-B1 | SKIN CARE COMPOSITION COMPRISING SKIN LIGHTENING AGENT | PROCTER & GAMBLE (US) | 2007-12-19 | — | — | EP | disclosed |
| EP-1663381-A1 | SONOPHORESIS SKIN CARE DEVICE | THE PROCTER & GAMBLE COMPANY (US) | 2006-06-07 | — | — | EP | disclosed |
| EP-1641428-A1 | SKIN CARE COMPOSITION COMPRISING SKIN LIGHTENING AGENT | THE PROCTER & GAMBLE COMPANY (US) | 2006-04-05 | — | — | EP | disclosed |
| US-7001355-B2 | Skin care device | THE PROCTER & GAMBLE COMPANY (US) | 2006-02-21 | — | — | US | disclosed |
| CN-1226983-C | transparent microemulsion | PROCTER & GAMBLE (US) | 2005-11-16 | — | — | CN | disclosed |
| CN-1224378-C | Skin care compositions | PROCTER & GAMBLE (US) | 2005-10-26 | — | — | CN | disclosed |
| CN-1507341-A | Skin care composition | — | 2004-06-23 | — | — | CN | disclosed |
| US-20040096414-A1 | Skin care composition | THE PROCTER & GAMBLE COMPANY | 2004-05-20 | — | — | US | disclosed |
| EP-1385471-A1 | SKIN CARE COMPOSITION | THE PROCTER & GAMBLE COMPANY (US) | 2004-02-04 | — | — | EP | disclosed |
| US-20040010222-A1 | Skin care device | THE PROCTER & GAMBLE COMPANY AND MATSUSHLTA ELECTRIC WORKS, LTD. (US) | 2004-01-15 | — | — | US | disclosed |
| EP-1178772-B1 | TRANSPARENT MICRO EMULSION | PROCTER & GAMBLE (US) | 2003-06-04 | — | — | EP | disclosed |
| US-6555119-B1 | Two or more nonionic surfactants, two or more oily components, a water-soluble high molecular weight polymer, and a cosmetically acceptable carrier. | THE PROCTER & GAMBLE COMPANY | 2003-04-29 | — | — | US | disclosed |
| WO-2002092046-A1 | SKIN CARE COMPOSITION | THE PROCTER & GAMBLE COMPANY (US) | 2002-11-21 | — | — | WO | disclosed |
| CN-1348353-A | Transparent micro emulsion | PROCTER & GAMBLE (US) | 2002-05-08 | — | — | CN | disclosed |
| EP-1178772-A1 | TRANSPARENT MICRO EMULSION | THE PROCTER & GAMBLE COMPANY (US) | 2002-02-13 | — | — | EP | disclosed |
| WO-2000061083-A1 | TRANSPARENT MICRO EMULSION | THE PROCTER & GAMBLE COMPANY (US) | 2000-10-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040096414-A1 | Skin care composition | CUTA, HACD3, IL36G | TSHR 3463/4885SMN1; SMN2 2168/4885DNM1 3781/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.